Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Phosphorylation of Parkin at serine 65 is essential for its activation in vivo.

McWilliams TG, Barini E, Pohjolan-Pirhonen R, Brooks SP, Singh F, Burel S, Balk K, Kumar A, Montava-Garriga L, Prescott AR, Hassoun SM, Mouton-Liger F, Ball G, Hills R, Knebel A, Ulusoy A, Di Monte DA, Tamjar J, Antico O, Fears K, Smith L, Brambilla R, Palin E, Valori M, Eerola-Rautio J, Tienari P, Corti O, Dunnett SB, Ganley IG, Suomalainen A, Muqit MMK.

Open Biol. 2018 Nov 7;8(11). pii: 180108. doi: 10.1098/rsob.180108.

2.

Probes of ubiquitin E3 ligases enable systematic dissection of parkin activation.

Pao KC, Stanley M, Han C, Lai YC, Murphy P, Balk K, Wood NT, Corti O, Corvol JC, Muqit MM, Virdee S.

Nat Chem Biol. 2016 May;12(5):324-31. doi: 10.1038/nchembio.2045. Epub 2016 Mar 7.

3.

The clinical atlas of Greig cephalopolysyndactyly syndrome.

Balk K, Biesecker LG.

Am J Med Genet A. 2008 Mar 1;146A(5):548-57. doi: 10.1002/ajmg.a.32167.

PMID:
18241058
4.

Recommended newborn screening policy change for the NICU infant.

Balk KG.

Policy Polit Nurs Pract. 2007 Aug;8(3):210-9. doi: 10.1177/1527154407309049. Review.

PMID:
18178928
5.

Newborn screening guidelines for the critically ill infant.

Balk KG.

Neonatal Netw. 2005 Sep-Oct;24(5):39-42. Review.

PMID:
16279054
6.

Synthesis and SAR studies for the inhibition of TNF-alpha production. Part 2. 2-[3-(Cyclopentyloxy)-4-methoxyphenyl]-substituted-1-isoindolinone derivatives.

Park JS, Moon SC, Baik KU, Cho JY, Yoo ES, Byun YS, Park MH.

Arch Pharm Res. 2002 Apr;25(2):137-42. Erratum in: Arch Pharm Res 2002 Jun;25(3):397. Balk Kyung Up [corrected to Baik Kyong Up].

PMID:
12009025
7.

Synthesis and structure-activity relationships of novel compounds for the inhibition of TNF-alpha production.

Park JS, Balk KU, Son HJ, Lee JH, Lee SJ, Cho JY, Park J, Yoo ES, Byun YS, Park MH.

Arch Pharm Res. 2000 Aug;23(4):332-7.

PMID:
10976579
8.

Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21.

Blouin JL, Dombroski BA, Nath SK, Lasseter VK, Wolyniec PS, Nestadt G, Thornquist M, Ullrich G, McGrath J, Kasch L, Lamacz M, Thomas MG, Gehrig C, Radhakrishna U, Snyder SE, Balk KG, Neufeld K, Swartz KL, DeMarchi N, Papadimitriou GN, Dikeos DG, Stefanis CN, Chakravarti A, Childs B, Housman DE, Kazazian HH, Antonarakis S, Pulver AE.

Nat Genet. 1998 Sep;20(1):70-3.

PMID:
9731535
9.

An antibacterial local anesthetic agent in the treatment of oropharyngeal conditions.

PRINTZ PA, BALK KC, CHEVICO P, ROBINSON MS, PRINTZ S.

Clin Med (Northfield). 1962 May;69:1161-4. No abstract available.

PMID:
15445853

Supplemental Content

Support Center